Director, SAKURASAKU PLUS,Co.,Ltd
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) and dividends retained by asset-management companies (less about 20% corporate tax), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
Asset-management companies: 株式会社クリエイトバリューest. (their holdings are included in net worth)
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| SAKURASAKU PLUS,Co.,Ltd 7097 · FY ending Jul 2026 |
株式会社クリエイトバリュー | 162,000 | 3.73% | ¥2,747 | ¥445M | ¥4.5M |
| SAKURASAKU PLUS,Co.,Ltd 7097 · FY ending Jul 2026 · Director |
Own name | 123,000 | 2.83% | ¥2,747 | ¥338M | ¥3.4M |
| Fuji Pharma Co.,Ltd. 4554 · FY ending Sep 2025 · President & Representative Director |
Own name | 4,241 | — | ¥1,545 | ¥6.6M | ¥192,965 |
| Year | Net worth | Pay | Dividends | Total income | Taxes (est.) | After tax (est.) |
|---|---|---|---|---|---|---|
| 2026 | ¥783M | ¥23.7M | ¥8.0M | ¥31.6M | ¥8.7M | ¥16.4M |
| 2025 | ¥727M | ¥59.9M | ¥7.0M | ¥66.9M | ¥27.9M | ¥33.1M |
Grouped by the calendar year of each company's fiscal year-end. Years in which the person was not among the top 10 shareholders of a company exclude that company.